Reuters - Health Report

Click to View in Browser

Tuesday, September 19, 2017

GlaxoSmithKline breathes easier as U.S. approves triple lung drug

LONDON (Reuters) - U.S. regulators have approved GlaxoSmithKline's three-in-one inhaler for chronic lung disease, a key new product for the group as it strives to keep its lead in respiratory medicine despite falling sales of the older drug Advair.

U.S. AIDS strategy to focus on 13 countries close to controlling epidemic

(Reuters) - The United States will concentrate its resources on 13 countries with high levels of HIV that have the best chance of controlling the AIDS epidemic under a strategy unveiled on Tuesday.

LONDON (Reuters) - The long-heralded threat of cut-price competition to its top-selling biological cancer medicines is finally becoming a reality for Roche, the world's biggest maker of oncology treatments.

Democrats urge full review before Senate vote on Obamacare attack

WASHINGTON (Reuters) - Democratic leaders in the U.S. Congress on Monday demanded that lawmakers wait to find out the budgetary and healthcare impacts of a new, last-ditch legislative effort by Republicans to repeal Obamacare before voting on it.

Costly drugs to weigh on U.S. employers' expenses in 2018: survey

(Reuters) - U.S. employers are bracing for higher health care expenses in 2018 as spending on new drugs to treat diseases such as cancer, multiple sclerosis and hepatitis C is expected to rise more than 7 percent, according to consultancy firm Mercer.

Nabriva's pneumonia drug succeeds in late-stage trial, shares soar

(Reuters) - Nabriva Therapeutics Plc shares nearly doubled in morning trading on Monday after the company said its experimental antibiotic for community-acquired bacterial pneumonia (CABP) met the main goal of a late-stage study.

WHO plans global war on cholera as Yemen caseload nears 700,000

GENEVA (Reuters) - The World Health Organization will next month launch a strategy to stop cholera transmission by 2030, it said on Monday, as an unprecedented outbreak in Yemen raced towards 700,000 suspected cases with little sign of slowing down.

Bayer halts non-U.S. sales of its contraceptive implant

(Reuters) - German drugs and pesticides group Bayer AG said in a statement on its French website that it would stop selling its contraceptive implant, Essure, in countries other than the United States.

Triathlon deaths not rare, and risks rise with age

(Reuters Health) - Triathlon competitors may be more likely to die suddenly and suffer a fatal trauma or cardiac arrest than previously thought, U.S. data suggest.

Pregnant moms who take folic acid cut autism risk from pesticides

(Reuters Health) - Children whose mothers took folic acid supplements early in their pregnancies were less likely to develop autism, even when the pregnant moms were exposed to pesticides linked to the neurodevelopmental disorder, a new study found.